Skip to main content
OpenTrials

Clinical trial condition

Adnexal Diseases

Explore clinical trials studying Adnexal Diseases. Study availability and eligibility vary by location and protocol.

3,502 public trials 676 recruiting studies
Refine in advanced search Browse all conditions

Adnexal Diseases trial results

Recruiting

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

NCT04751435

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +38 more
Locations
  • Kings County Hopsital Center Brooklyn, New York, United States
  • Queens Cancer Center of Queens Hospital Jamaica, New York, United States
  • Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities) New York, United States
  • Jamaica Hospital Medical Center (Data Collection Only) Richmond Hill, New York, United States
View Trial Details
Recruiting

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

NCT07218809

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site La Jolla, California, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 299 locations
View Trial Details
Recruiting

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

NCT07023627

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Usa Health Mitchell Cancer Institute Mobile, Alabama, United States
  • University of California, Los Angeles Medical Center Los Angeles, California, United States
  • Scripps Healthscripps Mercy Hospital Prebys Cancer Center San Diego, California, United States
  • Medstar Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 74 locations
View Trial Details
Recruiting

Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer

NCT07564141

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Danbury Hospital Danbury, Connecticut, United States
  • ProHealth Care Inc Waukesha, Wisconsin, United States
View Trial Details
Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

NCT06293898

Conditions
Adnexal Diseases, Biliary Tract Cancer, Biliary Tract Diseases, +51 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Cedars Sinai Los Angeles, California, United States
  • Scripps Health San Diego, California, United States
View all 17 locations
View Trial Details
Recruiting

A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

NCT07546500

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Site 0107 Phoenix, Arizona, United States
  • Site 0110 Antioch, California, United States
  • Site 0115 San Francisco, California, United States
  • Site 0101 Torrance, California, United States
View all 58 locations
View Trial Details
Recruiting

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

NCT07186842

Conditions
Adnexal Diseases, Advanced Solid Cancers, Bile Duct Diseases, +29 more
Locations
  • SCRI at HCA Health One Denver, Colorado, United States
  • Florida Cancer Specialists Orlando, Florida, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Monash Health Clayton, Australia
View all 16 locations
View Trial Details

Related conditions